h1

h2

h3

h4

h5
h6


001     1007648
005     20250719052322.0
024 7 _ |a eva578704
|2 HSB
024 7 _ |a 2152-2650
|2 ISSN
024 7 _ |a 2152-2669
|2 ISSN
024 7 _ |a SCOPUS:2-s2.0-85184267458
|2 SCOPUS
024 7 _ |a WOS:001221080700001
|2 WOS
024 7 _ |a 10.1016/j.clml.2024.01.005
|2 doi
024 7 _ |a pmid:38278737
|2 pmid
024 7 _ |a 10.18154/RWTH-CONV-254031
|2 datacite_doi
037 _ _ |a RWTH-CONV-254031
041 _ _ |a English
100 1 _ |a Kantarjian, Hagop M.
|b 0
|e Corresponding author
245 _ _ |a A Review of the Therapeutic Role of Bosutinib in Chronic Myeloid Leukemia
|h online
260 _ _ |c 2024
336 7 _ |0 0
|2 EndNote
|a Journal Article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
591 _ _ |a Canada
591 _ _ |a Germany
591 _ _ |a Italy
591 _ _ |a USA
700 1 _ |a Jabbour, Elias J.
|b 1
700 1 _ |a Lipton, Jeffrey H.
|b 2
700 1 _ |a Castagnetti, Fausto
|b 3
700 1 _ |0 P:(DE-82)IDM06025
|a Brümmendorf, Tim Henrik
|b 4
|u rwth
773 _ _ |0 PERI:(DE-600)2540998-0
|a 10.1016/j.clml.2024.01.005
|n 5
|p 285-297
|t Clinical lymphoma, myeloma & leukemia
|v 24
|x 2152-2650
856 4 _ |u https://publications.rwth-aachen.de/record/1007648/files/1007648.pdf
|y OpenAccess
909 C O |o oai:publications.rwth-aachen.de:1007648
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)IDM06025
|a RWTH Aachen
|b 4
|k RWTH
914 1 _ |y 2024
915 1 _ |0 StatID:(DE-HGF)0031
|2 StatID
|a Peer reviewed article
|x 0
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-26
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CL LYMPH MYELOM LEUK : 2022
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-26
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-26
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-10-26
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-26
920 1 _ |0 I:(DE-82)531040-2_20140620
|k 531040-2
|l Klinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Onkologie und Hämatologie)
|x 0
970 _ _ |a eva578704
980 _ _ |a I:(DE-82)531040-2_20140620
980 _ _ |a UNRESTRICTED
980 _ _ |a VDB
980 _ _ |a journal
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21